Phase II Clinical Study Combining Trastuzumab With Etoposide in Treatment of HER2-Positive Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Etoposide; Trastuzumab
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Jul 2010 Planned end date changed from 1 Jan 2013 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 07 Jul 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.